BackIntensity Therapeutics Overview
Intensity Therapeutics Inc

Intensity Therapeutics Target Price

Analysts' average 12-month price target for Intensity Therapeutics is $11.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.25

Average Target Price

$11.00238.5% upside

2 analysts in the last 4 months

High: $15 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-19H.C. WainwrightSwayampakula Ramakanth$7115.4% upsideOpen
2026-08-11Industrial Alliance SecuritiesJames Molloy$15361.5% upsideOpen
2024-10-31H.C. WainwrightSwayampakula Ramakanth$1253746.2% upsideOpen

Intensity Therapeutics (INTS) FAQ

The latest target price for INTS is $11. Investors often review this figure alongside Intensity Therapeutics's historical trend and sector peers before judging valuation or financial health.

Intensity Therapeutics trades near $3.25 while the consensus target sits at $11 (238.5% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting INTS's target price ($11), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.